Neuromuscular DiseasesNeuromuscular DiseasesНервно-мышечные болезни2222-87212413-0443Publishing House ABV Press6610.17650/2222-8721-2013-0-4-34-42CLINICAL CASEКЛИНИЧЕСКИЙ РАЗБОРLambert Eaton myasthenic syndrome and pregnancies with the development of transient myasthenic syndrome in newbornМиастенический синдром Ламберта–Итона на фоне беременности с развитием транзиторного миастенического синдрома новорожденногоShcherbakovaN. I.ЩербаковаН. И.Russian Federationshnata@inbox.ruGurkinaG. T.ГуркинаГ. Т.Russian FederationKasatkinaL. F.КасаткинаЛ. Ф.Russian FederationRudnichenkoV. A.РудниченкоВ. А.Russian FederationGalkinaO. I.ГалкинаО. И.Russian FederationShvedkovV. V.ШведковВ. В.Russian FederationRetinskayaI. G.РетинскаяИ. Г.Russian FederationPavlovE. V.ПавловЭ. В.Russian FederationShabalinаA. A.ШабалинаА. А.Russian FederationKostyrevaM. V.КостыреваМ. В.Russian FederationResearch Center of Neurology, Russian Academy of Medical Sciences, MoscowФГБУ «Научный центр неврологии» РАМН, Москва201220133434422002201520022015Copyright ©; 2013, Shcherbakova N.I., Gurkina G.T., Kasatkina L.F., Rudnichenko V.A., Galkina O.I., Shvedkov V.V., Retinskaya I.G., Pavlov E.V., Shabalinа A.A., Kostyreva M.V.Copyright ©; 2013, Щербакова Н.И., Гуркина Г.Т., Касаткина Л.Ф., Рудниченко В.А., Галкина О.И., Шведков В.В., Ретинская И.Г., Павлов Э.В., Шабалина А.А., Костырева М.В.2013Shcherbakova N.I., Gurkina G.T., Kasatkina L.F., Rudnichenko V.A., Galkina O.I., Shvedkov V.V., Retinskaya I.G., Pavlov E.V., Shabalinа A.A., Kostyreva M.V.Щербакова Н.И., Гуркина Г.Т., Касаткина Л.Ф., Рудниченко В.А., Галкина О.И., Шведков В.В., Ретинская И.Г., Павлов Э.В., Шабалина А.А., Костырева М.В.https://creativecommons.org/licenses/by/4.0https://nmb.abvpress.ru/jour/article/view/66Lambert–Eaton myasthenic syndrometransient neonatal Lambert–Eaton myasthenic syndrometransient neonatal myasthenia gravisvoltage-gates calcium channel autoantibodiespregnancylaborpostpartum mothers worseningneuromuscular transmissionмиастенический синдром Ламберта–Итонатранзиторный неонатальный миастенический синдром Ламберта–Итонатранзиторная неонатальная миастенияаутоантитела к потенциалзависимым кальциевым каналамбеременностьроды[1. Санадзе А.Г., Сиднев Д.В., Щербакова Н.И., Карганов М.Ю. Миастенический синдром Ламберта–Итона. Журн неврол и психиатр 2008;108(3):4–10.Санадзе А.Г., Сиднев Д.В., Щербакова Н.И., Карганов М.Ю. Миастенический синдром Ламберта–Итона. Журн неврол и психиатр 2008;108(3):4–10.][2. Щербакова Н.И., Ланцова В.Б. Миастенический синдром Ламберта–Итона: особенности иммунного ответа. Механизмы развития и принципы лечения заболеваний периферической нервной системы. Под ред. Е.И. Гусева, Н.Н. Яхно, А.Г. Санадзе, Л.Ф. Касаткиной. М., 2007; с. 166–171.Щербакова Н.И., Ланцова В.Б. Миастенический синдром Ламберта–Итона: особенности иммунного ответа. Механизмы развития и принципы лечения заболеваний периферической нервной системы. Под ред. Е.И. Гусева, Н.Н. Яхно, А.Г. Санадзе, Л.Ф. Касаткиной. М., 2007; с. 166–171.][3. Gilhus N.E. Lambert Eaton myasthenic syndrome; pathogenesis, diagnosis, and therapy. Autoimmune Dis 2011;973808:1–5.Gilhus N.E. Lambert Eaton myasthenic syndrome; pathogenesis, diagnosis, and therapy. Autoimmune Dis 2011;973808:1–5.][4. Lang B., Pinto A., Glovannini F., et al. Pathogenic autoantibodies in the Lambert Eaton myasthenic syndrome. Ann NY Acad Sci 2003;998:187–95.Lang B., Pinto A., Glovannini F., et al. Pathogenic autoantibodies in the Lambert Eaton myasthenic syndrome. Ann NY Acad Sci 2003;998:187–95.][5. Sakai W., Nakane S., Matsuo H. Autoantibody against the presynaptic P/Qtype voltage-gated calcium channel in Lambert Eaton myasthenic syndrome. Brain Nerve 2013;65(4):441–8.Sakai W., Nakane S., Matsuo H. Autoantibody against the presynaptic P/Qtype voltage-gated calcium channel in Lambert Eaton myasthenic syndrome. Brain Nerve 2013;65(4):441–8.][6. Vincent A., Beeson D., Lang B. Molecular targets for autoimmune and genetic disorders of neuromuscular transmission Eur J Biochem 2000;267(23):6717–28.Vincent A., Beeson D., Lang B. Molecular targets for autoimmune and genetic disorders of neuromuscular transmission Eur J Biochem 2000;267(23):6717–28.][7. Гехт Б.М., Ильина Н.А. Нервно-мышечные болезни. М.: Медицина, 1982; с. 314– 324.Гехт Б.М., Ильина Н.А. Нервно-мышечные болезни. М.: Медицина, 1982; с. 314– 324.][8. Hoff J.M., Daltveit A.K., Gilhus N.E. Myasthenia gravis in pregnancy and birth: identifying risk factors, optimising care. Eur J Neurol 2007;14(1):38–43.Hoff J.M., Daltveit A.K., Gilhus N.E. Myasthenia gravis in pregnancy and birth: identifying risk factors, optimising care. Eur J Neurol 2007;14(1):38–43.][9. Bayrak A.O., Sandikci U., Yon S.K., Onar M.K. Manifestation of Lambert Eaton myasthenic syndrome during last trimester of pregnancy. Int J Neurosci 2010;120(6 ):439–41.Bayrak A.O., Sandikci U., Yon S.K., Onar M.K. Manifestation of Lambert Eaton myasthenic syndrome during last trimester of pregnancy. Int J Neurosci 2010;120(6 ):439–41.][10. Lambert E.H., Eaton L.M., Rooke E.D. Defect of neuromuscular conduction associated with malignant neoplasms. Am J Physiol 1956;187:612–3.Lambert E.H., Eaton L.M., Rooke E.D. Defect of neuromuscular conduction associated with malignant neoplasms. Am J Physiol 1956;187:612–3.][11. Lecky B.R. Transient neonatal Lambert Eaton syndrome. J Neurol Neurosurg Psychiatry 2006;77(9):1094. 12. Reuner U., Kamin G., Ramantani G. et al. Transient neonatal Lambert-Eaton syndrome. J Neurol 2008;255(11):1827–8.Lecky B.R. Transient neonatal Lambert Eaton syndrome. J Neurol Neurosurg Psychiatry 2006;77(9):1094. 12. Reuner U., Kamin G., Ramantani G. et al. Transient neonatal Lambert-Eaton syndrome. J Neurol 2008;255(11):1827–8.][13. Schneider-Gold C., Wessig C., Höpker M. et al. Pregnancy and delivery of a healthy baby in autoimmune Lambert Eaton myasthenic syndrome. J Neurol 2006;253(9):1236–7.Schneider-Gold C., Wessig C., Höpker M. et al. Pregnancy and delivery of a healthy baby in autoimmune Lambert Eaton myasthenic syndrome. J Neurol 2006;253(9):1236–7.][14. Vinke M., Lehnen H. Two uncomplicated pregnancies and births in a patient with longstanding Lambert Eaton myasthenic syndrome. Geburtsh-Frauenheilkd, 2007;67:367–9.Vinke M., Lehnen H. Two uncomplicated pregnancies and births in a patient with longstanding Lambert Eaton myasthenic syndrome. Geburtsh-Frauenheilkd, 2007;67:367–9.][15. Kostera-Pruszczyk A., Ryniewicz B., Rowinska-Marcinska K. et al. Lambert Eaton myasthenic syndrome in childhood. Eur J Paediatr Neurol 2009;13(2):194–6.Kostera-Pruszczyk A., Ryniewicz B., Rowinska-Marcinska K. et al. Lambert Eaton myasthenic syndrome in childhood. Eur J Paediatr Neurol 2009;13(2):194–6.][16. Tsao C.Y., Mendell J.R., Friemer M.L., Kissel J.T. Lambert Eaton myasthenic syndrome in children. J hild Neurol 2002;17(1):74–6.Tsao C.Y., Mendell J.R., Friemer M.L., Kissel J.T. Lambert Eaton myasthenic syndrome in children. J hild Neurol 2002;17(1):74–6.][17. Arai H., Inui K., Hashimoto K. et al. Pulmonary adenocarcinoma, Lambert–Eaton myasthenic syndrome, and voltage-gated calcium channels: a case report. J Med Case Rep 2012;5(1):281.Arai H., Inui K., Hashimoto K. et al. Pulmonary adenocarcinoma, Lambert–Eaton myasthenic syndrome, and voltage-gated calcium channels: a case report. J Med Case Rep 2012;5(1):281.][18. Morimoto M., Osaki T., Nagara Y. et al. Thymoma with Lambert Eaton myasthenic syndrome. Ann Thorac Surg 2010;89(6):2001–3.Morimoto M., Osaki T., Nagara Y. et al. Thymoma with Lambert Eaton myasthenic syndrome. Ann Thorac Surg 2010;89(6):2001–3.][19. Djelmis J., Sostarko M., Mayer D., Ivanisevic M. Myasthenia gravis in pregnancy: report on 69 cases. Eur J Obstet Gynecol Reprod Biol 2002;1049(1):21–5.Djelmis J., Sostarko M., Mayer D., Ivanisevic M. Myasthenia gravis in pregnancy: report on 69 cases. Eur J Obstet Gynecol Reprod Biol 2002;1049(1):21–5.][20. O'carroll P., Bertorini T.E., Jacob G. et al. Transient neonatal myasthenia gravis in a baby born to a mother with new-onset anti-MuSKmediated myasthenia gravis. J Clin Neuromuscul Dis 2009;11(2):69–71.O'carroll P., Bertorini T.E., Jacob G. et al. Transient neonatal myasthenia gravis in a baby born to a mother with new-onset anti-MuSKmediated myasthenia gravis. J Clin Neuromuscul Dis 2009;11(2):69–71.][21. Ferrero S., Pretta S., Nicoletti A. et al. Myasthenia gravis: management issues during pregnancy. Eur J Obstet Gynecol Reprod Biol 2005;121(2):129 38.Ferrero S., Pretta S., Nicoletti A. et al. Myasthenia gravis: management issues during pregnancy. Eur J Obstet Gynecol Reprod Biol 2005;121(2):129 38.][22. Hatada Y., Munemura M., Matsuo I. et al. Myasthenic crisis in the puerperium: the possible importance of alpha-fetoprotein. Case report. Br J Obstet Gynaecol 1987;94(5):480–2.Hatada Y., Munemura M., Matsuo I. et al. Myasthenic crisis in the puerperium: the possible importance of alpha-fetoprotein. Case report. Br J Obstet Gynaecol 1987;94(5):480–2.][23. Terrero A., Ramírez-Rivera J. «Seronegative» anti-MUSK positive myasthenia gravis presenting during pregnancy. Bol Asoc Med P R 2006;98(3):210–2.Terrero A., Ramírez-Rivera J. «Seronegative» anti-MUSK positive myasthenia gravis presenting during pregnancy. Bol Asoc Med P R 2006;98(3):210–2.][24. Baslo M.B., Deymeer F., Serdaroglu P. et al. Decrement pattern in Lambert-Eaton myasthenic syndrome is different from myasthenia gravis. Neuromuscul Disord 2006;16(7):454–8.Baslo M.B., Deymeer F., Serdaroglu P. et al. Decrement pattern in Lambert-Eaton myasthenic syndrome is different from myasthenia gravis. Neuromuscul Disord 2006;16(7):454–8.][25. Luigetti M., Modoni A., Lo Monaco M. Low rate repetitive nerve stimulation in Lambert-Eaton myasthenic syndrome: peculiar characteristics of decremental pattern from a single-centre experience. Clin Neurophysiol 2013;124(4):819–27.Luigetti M., Modoni A., Lo Monaco M. Low rate repetitive nerve stimulation in Lambert-Eaton myasthenic syndrome: peculiar characteristics of decremental pattern from a single-centre experience. Clin Neurophysiol 2013;124(4):819–27.][26. Heininger K., Edler C., Toyka K.V. alpha-Fetoprotein and neonatal transient myasthenia gravis. Neurology 1984;34(3):403–4.Heininger K., Edler C., Toyka K.V. alpha-Fetoprotein and neonatal transient myasthenia gravis. Neurology 1984;34(3):403–4.][27. Kanzaki A., Motomura M. A pregnant patient with anti-MuSK antibody positive myasthenia gravis and her infant with transient neonatal myasthenia gravis. Rinsho Shinkeigaku 2011;51(3):18891.Kanzaki A., Motomura M. A pregnant patient with anti-MuSK antibody positive myasthenia gravis and her infant with transient neonatal myasthenia gravis. Rinsho Shinkeigaku 2011;51(3):18891.][28. Riemersma S., Vincent A., Beeson D. et al. Association of arthrogryposis multiplex congenita with maternal antibodies inhibiting fetal acetylcholine receptor function. J Clin Invest1996;98(10):2358–63.Riemersma S., Vincent A., Beeson D. et al. Association of arthrogryposis multiplex congenita with maternal antibodies inhibiting fetal acetylcholine receptor function. J Clin Invest1996;98(10):2358–63.][29. Chieza J.T., Fleming I., Parry N., Skelton V.A. Maternal myasthenia gravis complicated by fetal arthrogryposis multiplex congenital. Int J Obstet Anesth 2011;20(1):79–82.Chieza J.T., Fleming I., Parry N., Skelton V.A. Maternal myasthenia gravis complicated by fetal arthrogryposis multiplex congenital. Int J Obstet Anesth 2011;20(1):79–82.][30. Hoff J.M., Daltveit A.K., Gilhus N.E. Artrogryposis multiplex congenita a rare fetal condition caused by maternal myasthenia gravis. Acta Neurol Scand Suppl 2006;183:26–7.Hoff J.M., Daltveit A.K., Gilhus N.E. Artrogryposis multiplex congenita a rare fetal condition caused by maternal myasthenia gravis. Acta Neurol Scand Suppl 2006;183:26–7.][31. Mikou F., Kaouti N., Ghazli M. et al. Severe neonatal myasthenia with arthrogryposis. J Gynecol Obstet Biol Reprod (Paris) 2003;32(7):660–2.Mikou F., Kaouti N., Ghazli M. et al. Severe neonatal myasthenia with arthrogryposis. J Gynecol Obstet Biol Reprod (Paris) 2003;32(7):660–2.][32. Brenner T., Beyth Y., Abramsky O. Inhibitory effect of alpha-fetoprotein on the binding of myasthenia gravis antibody to acetylcholine receptor. Proc Natl Acad Sci USA 1980;779(6):3635–9.Brenner T., Beyth Y., Abramsky O. Inhibitory effect of alpha-fetoprotein on the binding of myasthenia gravis antibody to acetylcholine receptor. Proc Natl Acad Sci USA 1980;779(6):3635–9.][33. Brenner T., Abramsky O., Lisak R.P. Influence of alpha-fetoprotein on the in vitro and in vivo immune response to acetylcholine receptor. Ann N Y Acad Sci 1981;377:208–21.Brenner T., Abramsky O., Lisak R.P. Influence of alpha-fetoprotein on the in vitro and in vivo immune response to acetylcholine receptor. Ann N Y Acad Sci 1981;377:208–21.]